Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?

被引：11
|
作者：
Varghese, Ryan [1 ,2 ]
Kumar, Dileep [1 ,3 ,4 ]
Sharma, Rohit [5 ]
机构：
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Pune 411038, Maharashtra, India
[2] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Dept Clin Pharmacol, Kharghar 410210, Navi Mumbai, India
[3] Univ Calif Davis, Dept Entomol, One Shields Ave, Davis, CA 95616 USA
[4] Univ Calif Davis, UC Davis Comprehens Canc Ctr, One Shields Ave, Davis, CA 95616 USA
[5] Banaras Hindu Univ, Inst Med Sci, Fac Ayurveda, Dept Rasa Shastra & Bhaishajya Kalpana, Varanasi 221005, Uttar Pradesh, India
来源：
HUMAN CELL | 2023年 / 36卷 / 03期
关键词：
SARS-CoV-2; COVID-19; Variants; BF.7; BQ.1; BQ.1.1; XBB.1.5;
D O I：
10.1007/s13577-023-00903-9
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1218 / 1221
页数：4
相关论文
共 32 条
  • [1] Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern?
    Ryan Varghese
    Dileep Kumar
    Rohit Sharma
    Human Cell, 2023, 36 : 1218 - 1221
  • [2] Renewed global threat by the novel SARS-CoV-2 variants 'XBB, BF.7, BQ.1, BA.2.75, BA.4.6': A discussion
    Mohapatra, Ranjan K.
    Mahal, Ahmed
    Kutikuppala, L. V. Simhachalam
    Pal, Madhumita
    Kandi, Venkataramana
    Sarangi, Ashish K.
    Obaidullah, Ahmad J.
    Mishra, Snehasish
    FRONTIERS IN VIROLOGY, 2022, 2
  • [3] Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
    Bellusci, Lorenza
    Grubbs, Gabrielle
    Sait, Shaimaa
    Yonker, Lael M.
    Randolph, Adrienne G.
    Novak, Tanya
    Kobayashi, Takuma
    Khurana, Surender
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [4] Never ending story? Evolution of SARS-CoV-2 monitored through Gibbs energies of biosynthesis and antigen-receptor binding of Omicron BQ.1, BQ.1.1, XBB and XBB.1 variants
    Popovic, Marko
    MICROBIAL RISK ANALYSIS, 2023, 23
  • [5] Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld
    Zhao, Qianqian
    Wang, Xin
    Zhang, Ze
    Liu, Xuefei
    Wang, Ping
    Cao, Jin
    Liang, Qiming
    Qu, Jieming
    Zhou, Min
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (07)
  • [6] Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters
    Case, James Brett
    Scheaffer, Suzanne M.
    Darling, Tamarand L.
    Bricker, Traci L.
    Adams, Lucas J.
    Harastani, Houda H.
    Trende, Reed
    Sanapala, Shilpa
    Fremont, Daved H.
    Boon, Adrianus C. M.
    Diamond, Michael S.
    JOURNAL OF VIROLOGY, 2023, 97 (09) : e0062823
  • [7] Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ.1.1, CA.3.1, CH.1.1, XBB.1.16, and XBB.1.5
    Entzminger, Kevin C.
    Fleming, Jonathan K.
    Entzminger, Paul D.
    Espinosa, Lisa Yuko
    Samadi, Alex
    Hiramoto, Yuko
    Okumura, Shigeru C. J.
    Maruyama, Toshiaki
    ANTIBODY THERAPEUTICS, 2023, 6 (02) : 108 - 118
  • [8] Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5
    Molina, Kyle C.
    Webb, Brandon J.
    Kennerley, Victoria
    Beaty, Laurel E.
    Bennett, Tellen D.
    Carlson, Nichole E.
    Mayer, David A.
    Peers, Jennifer L.
    Russell, Seth
    Wynia, Matthew K.
    Aggarwal, Neil R.
    Ginde, Adit A.
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [9] A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB
    Ding, Yuan
    Fan, Feng
    Xu, Xin
    Zhao, Gan
    Zhang, Xin
    Zhao, Huiyun
    Wang, Limei
    Wang, Bin
    Gao, Xiao-Ming
    VACCINES, 2023, 11 (04)
  • [10] Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
    Sutandhio, Silvia
    Furukawa, Koichi
    Kurahashi, Yukiya
    Marini, Maria Istiqomah
    Effendi, Gema Barlian
    Hasegawa, Natsumi
    Ishimaru, Hanako
    Nishimura, Mitsuhiro
    Arii, Jun
    Mori, Yasuko
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (07) : 1064 - 1072
1234